Top Media Providers

Mangoceuticals amends preferred stock terms and establishes new Series D shares

Investing.comBy Investing.com

11/13/2026, 10:44:46 PM

EXECUTIVE SUMMARY

Mangoceuticals amends preferred stock terms and establishes new Series D shares....

Mangoceuticals amends preferred stock terms and establishes new Series D shares.

Published originally on Investing.com

Finance & Markets26m ago

Adicet Bio announces board changes and committee appointments....

Investing.com

Finance & Markets28m ago

Q2 Holdings general counsel Michael Kerr sells $198,620 in stock....

Investing.com

Finance & Markets28m ago

Joint Corp director Charles Jobson buys $18,786 in shares....

Investing.com

Finance & Markets28m ago

Revolution Medicines CFO Jack Anders sells $6.7 million in stock....

Investing.com

Multikhabar App

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!